EO2463
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EO2463, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma [Phase 1, Phase 2]